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Case report
Paraganglioma of seminal vesicle and chromophobe renal 
cell carcinoma: a case report and literature review
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aBstraCt
CONTEXT: Extra-adrenal paragangliomas are rare tumors that have been reported in many locations, in-
cluding the kidney, urethra, urinary bladder, prostate, spermatic cord, gallbladder, uterus and vagina.
CASE REPORT: This report describes, for the first time to the best of our knowledge, a primary paragan-
glioma of the seminal vesicle occurring in a 61-year-old male. The patient presented persistent arterial 
hypertension and a previous diagnosis of chromophobe renal cell carcinoma. It was hypothesized that 
the seminal vesicle tumor could be a metastasis from the chromophobe renal cell carcinoma. Immunohis-
tochemical characterization revealed expression of synaptophysin and chromogranin in tumor cell nests 
and peripheral S100 protein expression in sustentacular cells. Succinate dehydrogenase A and B-related 
(SDHA and SDHB) expression was present in both tumors. 
CONCLUSIONS: No genetic alterations to the VHL and SDHB genes were detected in either the tumor 
tissue or tissues adjacent to the tumor, which led us to rule out a hereditary syndrome that could explain 
the association between paraganglioma and chromophobe renal cell carcinoma in a patient with arterial 
hypertension. 
resUMo
CONTEXTO: Paragangliomas extra-adrenais são tumores raros que têm sido relatados em muitas localiza-
ções, incluindo rim, uretra, bexiga, próstata, cordão espermático, vesícula biliar, útero e vagina.
RELATO DE CASO: Este relato descreve, pela primeira vez em nosso conhecimento, um paraganglioma 
primário da vesícula seminal ocorrendo em um paciente do sexo masculino de 61 anos de idade. O 
paciente apresentou hipertensão arterial persistente e um diagnóstico prévio de carcinoma de células 
renais cromófobo (CCRC). Foi pensado que o tumor de vesícula seminal poderia ser uma metástase do 
CCRC. A caracterização imunoistoquímica revelou expressão de sinaptofisina e cromogranina nos ninhos 
de células tumorais e expressão de proteína S100 nas células sustentaculares. Expressão de succinato 
de-hidrogenase A e B relacionada (SDHA e SDHB) estiveram presentes em ambos os tumores.
CONCLUSÕES: Nenhuma alteração genética dos genes VHL e SDHB foi detectada nos tecidos tumorais e 
adjacentes ao tumor, o que nos levou a afastar uma síndrome hereditária que poderia explicar a associa-
ção entre o paraganglioma e o CCRC em um paciente com hipertensão arterial.
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Paragangliomas are tumors of neural crest-derived endocrine cells or organs that originate in 
locations corresponding to the sites in which normal paraganglia occur (such as the head and 
neck region, vagus nerve and extra-adrenal region, i.e. the abdomen and thoracic sympathoa-
drenal neuroendocrine system) during development or in adulthood. The prototypical sym-
pathetic paraganglia are the adrenal medulla and the organ of Zuckerkandl. The prototypical 
parasympathetic paraganglia is the carotid body. Other paraganglia are microscopic and have 
variable locations.1 
Nearly 85% of paragangliomas are intra-abdominal, 12% are intrathoracic, and 3% are cer-
vical. Paragangliomas may occur in unusual sites, including the kidneys, urethra, urinary blad-
der, prostate, spermatic cord, gallbladder, uterus and vagina.2 
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To the best of our knowledge, this is the first reported case of 
a primary paraganglioma in the seminal vesicle. An additional 
occurrence was the association with a chromophobe renal cell 
carcinoma in the same patient (Table 1). 
CASE REPORT 
A 61-year-old obese male underwent laparoscopic partial nephre-
ctomy due to an incidental tumor in the left kidney that was found 
during a work-up for hypertension. Microscopic examination of 
the tumor revealed that this was a chromophobe renal cell carci-
noma. After one year of surveillance, a routine follow-up evalu-
ation revealed a tumor in the left seminal vesicle. Magnetic reso-
nance imaging (MRI) showed a well-circumscribed heterogeneous 
solid tumor in the left seminal vesicle measuring 32 mm across its 
largest dimension, with well-defined cleavage planes with the rec-
tum and bladder walls (Figure 1). The patient then underwent lap-
aroscopic surgical excision of the left seminal vesicle.
Grossly, the seminal vesicle measured 6 x 3 x 2 cm, and the 
cut surface showed a solid, well-circumscribed, brownish and 
smooth nodule measuring 30 mm across its largest dimension. 
The surgical margins were free from tumor. Microscopic exami-
nation of the tumor disclosed well-defined nests of cuboidal cells 
separated by vascular fibrous septa without evidence of vascular 
invasion, mitotic figures or necrosis. Gland-like structures were 
identified focally. The individual tumor cells had a large cen-
tral nucleus and small to medium-sized nucleoli, and granular 
eosinophilic cytoplasm (Figure 2).
The diagnostic possibilities at this point included metasta-
sis of the previous chromophobe renal cell carcinoma, adeno-
carcinoma of the seminal vesicle and paraganglioma. Immu-
nohistochemical characterization was used for the differential 
diagnosis (antibodies summarized in Table 2). The tumor cells 
were immunoreactive for chromogranin and synaptophysin 
(Figure 2). At the periphery of the tumor nests, S100 protein-
positive cells were identified, probably corresponding to sus-
tentacular cells, in the absence of tumor keratin expression 
(Figure 2). Absence of immunoreactivity for keratins (AE1/
AE3, CK7 and CK8/18) ruled out the hypothesis of primary 
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PubMed
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Table 1. Published papers relating to seminal vesicle 
paraganglioma associated with chromophobe renal cell 
carcinoma, according to database (March 16, 2011).
Table 2. List of antibodies used in the immunohistochemistry study
Antigen Origin Clone Dilution
CK7 Zymed OV-TL12/30 1/50
CD10 Novocastra NCL-L_CD10-270 1/10
Vimentin Dako V9 1/150
CK8/18 Cell Marque B22.1 & B23.1 1/50
AE1/AE3 Zymed AE1/AE3 1/50
Chromogranin Neomarkers SP12 1/200
Synaptophysin Cell Marque Polyclonal 1/300
S100 Dako S100 1/2000
Ki-67 Neomarkers Ki-67 (SP6) 1/300
SDHA Mitosciences Inc 2E3GC12FB2AE2 1/1250
SDHB Mitosciences Inc 21A11AE7 1/600
Figure 1. Paraganglioma of seminal vesicle seen on endorectal magnetic resonance imaging. A) T1-weighted axial image showing a 
slightly hyperintense solid mass in the left seminal vesicle (arrows).The presence of focal hyperintense areas within the mass is due 
to the hemorrhagic component of the lesion; B) T2-weighted axial image demonstrating that the mass (arrows) is predominantly 
hypointense. Note the normal appearance of the right seminal vesicle (*); C) Contrast enhanced, T1-weighted axial image showing that 
the lesion (arrows) presents a high degree of contrast enhancement. D) Macroscopic appearance: seminal vesicle with a brownish, well-
circumscribed smooth nodule measuring 30 mm. 
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or metastatic carcinoma, and supported the diagnosis of sem-
inal vesicle paraganglioma. The Ki-67 labeling index was less 
than 2%. VHL and SDHB mutations were investigated using 
genomic DNA extracted from paraffin-embedded tumor sec-
tions (both from the seminal vesicle tumor and from the chro-
mophobe renal cell carcinoma). No genetic alterations were 
found either in the VHL or in the SDHB genes. 
Thorough imaging analysis showed that there was no tumor 
elsewhere, which therefore reinforced the diagnosis of primary 
seminal vesicle paraganglioma. The patient is still alive after 14 
months of follow-up and his blood pressure is under control.
DISCUSSION
Parasympathetic ganglia-derived tumors are found almost exclu-
sively in the neck and skull base and arise within the carotid body 
and jugulotympanic glomus.3 In a review of 236 patients with para-
gangliomas, Erickson et al.4 found that 69% of paragangliomas were 
found in the head and neck region and that the majority were para-
sympathetic in origin. In contrast, sympathetic paragangliomas, also 
known as extra-adrenal pheochromocytomas, arise outside of the 
adrenal gland and can be found anywhere along the sympathetic 
chain from the base of the skull and neck (5% of cases) to the blad-
der and prostate gland (10%).3 About 90% of sympathetic paragan-
gliomas occur in adults and 90% of these are intra-adrenal (pheo-
chromocytomas). About half of the extra-adrenal sympathetic 
tumors arise in the organs of Zuckerkandl, and most of the remain-
der in the retroperitoneum. There is equal distribution between 
the sexes, except in children and in patients with thoracic tumors, 
among whom males are reported to be more commonly affected.5
There are some reports in the urology literature about 
paragangliomas located in the prostate, bladder and even the 
paratesticular region (six cases).2 The histogenesis of paragan-
gliomas of the spermatic cord is unknown, although it has been 
speculated that paraganglion nests in the spermatic cord may 
be secondary to dysgenesis during embryogenesis.2 The present 
study is the first report on primary paraganglioma of the sem-
inal vesicle. Its origin can be explained in the same way as for 
the spermatic cord, because the cells that give rise to the semi-
nal vesicle originate in the caudal Wolffian duct and urogenital 
sinus prostate.6
Paragangliomas and pheochromocytomas can occur spo-
radically or in the context of several inherited tumor syn-
dromes, including multiple endocrine neoplasia type 2 
(MEN2, with RET germline mutations), von Hippel-Lindau 
(VHL) disease (caused by germline mutations in the VHL 
gene), neurofibromatosis type 1 (NF1, with NF1 gene ger-
mline mutations) and pheochromocytoma-paraganglioma 
syndrome. The latter syndrome is the most frequent heredi-
tary condition with manifestations of paragangliomas, and is 
caused by mutations in the SDHB, SDHC or SDHD genes.3,7 
The syndrome is characterized by familial occurrence of pheo-
chromocytoma or paragangliomas, usually at a young age, and 
often with multifocal disease. In the setting of SDHB muta-
tions, the tumors show greater risk of recurrence and higher 
frequency of malignancy.3,7
In view of the rare association of paraganglioma and chromo-
phobe renal cell carcinoma in our patient (Table 1), the presence 
of VHL and SDHB mutations was investigated using genomic 
DNA extracted from paraffin-embedded tumor sections (both 
from the seminal vesicle tumor and from the chromophobe renal 
carcinoma). No genetic alterations were found either in the VHL 
or in the SDHB genes. 
Figure 2. Paraganglioma of seminal vesicle: low-power (A); high-power (B); negative expression of CK7 (C); diffuse positive expression of 
chromogranin (D); positive expression of S100 in sustentacular cells (E); and positive expression of SDHA (F) and SDHB (G). 
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CONCLUSIONS
In conclusion, this is the first report of a primary paraganglioma 
in the seminal vesicle, with an additional association with chro-
mophobe renal cell carcinoma (Table 1). Paragangliomas may 
occur sporadically or in hereditary syndromes associated or 
caused by VHL and SDHB mutations. Using genomic DNA 
extracted from paraffin-embedded sections through the tumors, 
no genetic alterations were found. Hence, the diagnosis of a spo-
radic primary tumor of the seminal vesicle was favored. 
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